Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Stevens

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 24, 2016
Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of InflammationSanjay Swaminathan, Ju Qiu, Adam W Rupert, et al.
The Journal of Infectious Diseases|August 5, 2003
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virusJorge A Tavel, Irini Sereti, Robert E Walker, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Health & Justice|August 29, 2024
Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitionersMilan F Satcher, Steven Belenko, Anthony Coetzer-Liversage, et al.
The Journal of Clinical Investigation|July 19, 2005
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patientsJoseph A Kovacs, Richard A Lempicki, Igor A Sidorov, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Plos One|September 15, 2022
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
Plos One|November 14, 2024
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 24, 2016
Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of InflammationSanjay Swaminathan, Ju Qiu, Adam W Rupert, et al.
The Journal of Infectious Diseases|August 5, 2003
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virusJorge A Tavel, Irini Sereti, Robert E Walker, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Health & Justice|August 29, 2024
Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitionersMilan F Satcher, Steven Belenko, Anthony Coetzer-Liversage, et al.
The Journal of Clinical Investigation|July 19, 2005
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patientsJoseph A Kovacs, Richard A Lempicki, Igor A Sidorov, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Plos One|September 15, 2022
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
Plos One|November 14, 2024
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.
Pageof 3